US Stock MarketDetailed Quotes

TRVI Trevi Therapeutics

Watchlist
  • 4.590
  • +0.230+5.28%
Close Jan 3 16:00 ET
  • 4.520
  • -0.070-1.53%
Post 20:01 ET
410.19MMarket Cap-10.43P/E (TTM)

Trevi Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Trevi Therapeutics Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
EPS
-0.12
-0.13
-0.01
Miss Est.
-45.43%
-62.50%
-11.88%
Net Income
--
-13.24M
--
-72.02%
Analyst Rating
Strong Buy

Jan 5, 2025

Trevi Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 6, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 7, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 6, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 7, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Trevi Therapeutics Earnings Reports

  • Trevi Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:26 ET

  • Trevi Therapeutics | 8-K: Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

    Nov 6, 2024 16:17 ET

  • Trevi Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:48 ET

  • Trevi Therapeutics | 8-K: Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance

    Aug 8, 2024 16:17 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 5, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data